The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 21, 2019
Filed:
May. 06, 2015
Applicant:
Armo Biosciences, Inc., Redwood City, CA (US);
Inventors:
John Brian Mumm, Los Altos Hills, CA (US);
Ivan Ho Chan, Redwood City, CA (US);
Assignee:
Armo Biosciences, Inc., Redwood City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/60 (2006.01); C07K 14/47 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/20 (2006.01); G01N 33/50 (2006.01); A61K 39/385 (2006.01); A61K 49/00 (2006.01); C07K 14/715 (2006.01); C07K 17/02 (2006.01); A61K 47/60 (2017.01); G01N 33/92 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 38/1796 (2013.01); A61K 38/2066 (2013.01); A61K 47/60 (2017.08); A61K 49/0008 (2013.01); C07K 14/4705 (2013.01); C07K 14/4718 (2013.01); C07K 14/715 (2013.01); C07K 17/02 (2013.01); G01N 33/5055 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C12Q 1/60 (2013.01); G01N 33/92 (2013.01);
Abstract
Methods of treating subjects having diseases, disorders, or conditions, including disorders associated with cholesterol homeostasis, responsive to agents modulating Kupffer cell function, including methods of administration and dosing regimens associated therewith, are provided. Methods of treating subjects having liver diseases, disorders, or conditions, including non-alcoholic steatohepatitis and non-alcoholic fatty liver disease, with an IL-10 agent are also provided.